Explore more publications!

Laayoune Tech Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Laayoune Tech Observer.

Press releases published on January 8, 2026

Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.
Lafayette Digital Acquisition Corp. I Announces Pricing of $250,000,000 Initial Public Offering
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
Singapore Students Prove Anyone Can Build AI: Codechella 2025 Redefines University Hackathons
PattiePump Swap Announces Groundbreaking PAPPE Token Supply & Distribution Platform Launch
Best Creatine Supplements for Women And Men 2026: Effective Creatine For Muscle Growth & Weight loss For Women Over 40, 50 - by Crazy Nutrition
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
Cellectis Announces 2026 Strategy and Catalysts
Cellectis annonce sa stratégie et ses jalons attendus en 2026
reAlpha to Host Live X Spaces Fireside Chat on Real-World AI Applications in Mortgage and Real Estate
BGIN BLOCKCHAIN LIMITED Announces Share Purchases by Chairman and Independent Director
Spyre Therapeutics Announces Grants of Inducement Awards
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
Astera Labs Announces Conference Call to Review Fourth Quarter 2025 Financial Results
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions